US Stock MarketDetailed Quotes

Organogenesis (ORGO)

Watchlist
  • 2.500
  • -0.050-1.96%
Close Apr 17 15:59 ET
  • 2.500
  • 0.0000.00%
Post 16:10 ET
321.60MMarket Cap16.67P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Organogenesis (ORGO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-172.56%-10.31M
260.43%39.42M
-64.59%3.08M
-793.82%-32.87M
-96.17%-19.94M
-54.04%14.21M
3.04%10.94M
-48.04%8.7M
-45.20%4.74M
-100.16%-10.16M
Net income from continuing operations
4,201.05%37.03M
469.53%43.7M
74.90%21.57M
44.89%-9.39M
-797.29%-18.84M
-82.59%861K
1,450.88%7.67M
289.48%12.33M
-420.60%-17.04M
29.27%-2.1M
Operating gains losses
-86.13%188K
-87.38%115K
190.00%29K
-71.26%25K
-94.52%19K
476.60%1.36M
595.42%911K
-74.36%10K
4,250.00%87K
450.79%347K
Depreciation and amortization
6.16%26.94M
9.24%7.01M
8.88%6.99M
4.62%6.66M
1.73%6.28M
8.21%25.37M
1.41%6.42M
9.80%6.42M
17.56%6.36M
5.34%6.18M
Deferred tax
188.63%9.5M
651.87%15.63M
-74.57%-3.84M
81.97%-1.03M
---1.27M
-632.75%-10.72M
-240.76%-2.83M
---2.2M
---5.69M
--0
Other non cash items
76.54%15.73M
209.97%7.56M
22.72%1.94M
14.19%2.45M
37.78%3.78M
10.59%8.91M
-19.19%2.44M
41.70%1.58M
-6.08%2.15M
67.60%2.74M
Change In working capital
-170.78%-132.38M
-544.17%-43.67M
-115.77%-29.88M
-404.23%-38.12M
-0.05%-20.71M
-170.51%-48.89M
-155.62%-6.78M
-558.09%-13.85M
-14.25%-7.56M
-75.04%-20.7M
-Change in receivables
-264.16%-115.8M
-484.71%-51.48M
-1,799.80%-50.69M
-77.75%-19.31M
137.49%5.67M
-674.11%-31.8M
-220.60%-8.8M
-7.07%2.98M
-604.80%-10.86M
-340.86%-15.12M
-Change in inventory
-188.77%-17.92M
-550.77%-2.96M
125.08%938K
-369.07%-7.16M
-86.98%-8.73M
24.15%-6.2M
35.55%-455K
-9.10%-3.74M
241.39%2.66M
-115.90%-4.67M
-Change in prepaid assets
92.82%-183K
107.25%3.12M
366.70%9.64M
-301.57%-7.82M
-18.73%-5.12M
74.80%-2.55M
126.72%1.5M
-123.62%-3.62M
104.16%3.88M
9.61%-4.32M
-Change in payables and accrued expense
45.07%9.85M
60.89%11.15M
277.89%10.95M
-523.08%-1.76M
-287.34%-10.49M
124.16%6.79M
565.86%6.93M
-188.41%-6.16M
113.49%416K
776.21%5.6M
-Change in other current liabilities
114.88%158K
-14.54%-1.31M
5,407.69%1.43M
----
----
-1,267.03%-1.06M
-5,065.22%-1.14M
2,500.00%26K
-42.22%26K
27.27%28K
-Change in other working capital
39.63%-8.49M
54.52%-2.19M
35.58%-2.16M
43.11%-2.11M
7.37%-2.04M
-66.68%-14.07M
-123.13%-4.81M
-58.98%-3.35M
-80.40%-3.71M
-3.63%-2.2M
Cash from discontinued investing activities
Operating cash flow
-172.56%-10.31M
260.43%39.42M
-64.59%3.08M
-793.82%-32.87M
-96.17%-19.94M
-54.04%14.21M
3.04%10.94M
-48.04%8.7M
-45.20%4.74M
-100.16%-10.16M
Investing cash flow
Cash flow from continuing investing activities
-41.06%-14.15M
-38.41%-4.65M
13.00%-2.24M
-93.51%-3.64M
-63.19%-3.63M
58.82%-10.03M
-1.11%-3.36M
57.03%-2.57M
74.93%-1.88M
70.62%-2.22M
Net PPE purchase and sale
-41.06%-14.15M
-38.41%-4.65M
13.00%-2.24M
-93.51%-3.64M
-63.19%-3.63M
58.82%-10.03M
-1.11%-3.36M
57.03%-2.57M
74.93%-1.88M
70.62%-2.22M
Cash from discontinued investing activities
Investing cash flow
-41.06%-14.15M
-38.41%-4.65M
13.00%-2.24M
-93.51%-3.64M
-63.19%-3.63M
58.82%-10.03M
-1.11%-3.36M
57.03%-2.57M
74.93%-1.88M
70.62%-2.22M
Financing cash flow
Cash flow from continuing financing activities
-162.81%-17.36M
-114.29%-4.81M
-508.65%-10.21M
83.32%-288K
21.17%-2.06M
602.03%27.64M
1,993.58%33.65M
-16.62%-1.68M
-63.85%-1.73M
-111.00%-2.61M
Net issuance payments of debt
98.27%-1.17M
99.52%-302K
82.40%-296K
82.79%-288K
82.91%-285K
-1,207.64%-67.64M
-3,421.99%-62.62M
-17.05%-1.68M
-64.02%-1.67M
-77.83%-1.67M
Net common stock issuance
--0
----
----
----
----
---25.48M
----
----
----
----
Net preferred stock issuance
--0
----
----
----
----
--120.69M
----
----
----
----
Proceeds from stock option exercised by employees
-87.41%157K
-99.81%2K
3,150.00%130K
--0
-86.11%25K
--1.25M
--1.06M
--4K
--0
--180K
Net other financing activities
-1,291.15%-16.35M
-225,350.00%-4.51M
-1,004,200.00%-10.04M
--0
-60.36%-1.8M
-253.92%-1.18M
-300.00%-2K
200.00%1K
-58.82%-54K
-275.84%-1.12M
Cash from discontinued financing activities
Financing cash flow
-162.81%-17.36M
-114.29%-4.81M
-508.65%-10.21M
83.32%-288K
21.17%-2.06M
602.03%27.64M
1,993.58%33.65M
-16.62%-1.68M
-63.85%-1.73M
-111.00%-2.61M
Net cash flow
Beginning cash position
30.49%136.15M
-32.19%64.37M
-18.50%73.74M
23.71%110.53M
30.49%136.15M
1.01%104.34M
-3.95%94.93M
1.08%90.48M
-0.08%89.35M
1.01%104.34M
Current changes in cash
-231.46%-41.82M
-27.33%29.96M
-310.45%-9.36M
-3,353.67%-36.8M
-70.87%-25.62M
2,935.59%31.81M
647.78%41.23M
-52.25%4.45M
1,116.13%1.13M
-8.05%-14.99M
End cash Position
-30.72%94.33M
-30.72%94.33M
-32.19%64.37M
-18.50%73.74M
23.71%110.53M
30.49%136.15M
30.49%136.15M
-3.95%94.93M
1.08%90.48M
-0.08%89.35M
Free cash flow
-685.73%-24.46M
358.92%34.77M
-86.22%844K
-1,377.50%-36.51M
-90.25%-23.56M
-36.27%4.18M
3.92%7.58M
-43.04%6.13M
149.17%2.86M
2.02%-12.38M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -172.56%-10.31M260.43%39.42M-64.59%3.08M-793.82%-32.87M-96.17%-19.94M-54.04%14.21M3.04%10.94M-48.04%8.7M-45.20%4.74M-100.16%-10.16M
Net income from continuing operations 4,201.05%37.03M469.53%43.7M74.90%21.57M44.89%-9.39M-797.29%-18.84M-82.59%861K1,450.88%7.67M289.48%12.33M-420.60%-17.04M29.27%-2.1M
Operating gains losses -86.13%188K-87.38%115K190.00%29K-71.26%25K-94.52%19K476.60%1.36M595.42%911K-74.36%10K4,250.00%87K450.79%347K
Depreciation and amortization 6.16%26.94M9.24%7.01M8.88%6.99M4.62%6.66M1.73%6.28M8.21%25.37M1.41%6.42M9.80%6.42M17.56%6.36M5.34%6.18M
Deferred tax 188.63%9.5M651.87%15.63M-74.57%-3.84M81.97%-1.03M---1.27M-632.75%-10.72M-240.76%-2.83M---2.2M---5.69M--0
Other non cash items 76.54%15.73M209.97%7.56M22.72%1.94M14.19%2.45M37.78%3.78M10.59%8.91M-19.19%2.44M41.70%1.58M-6.08%2.15M67.60%2.74M
Change In working capital -170.78%-132.38M-544.17%-43.67M-115.77%-29.88M-404.23%-38.12M-0.05%-20.71M-170.51%-48.89M-155.62%-6.78M-558.09%-13.85M-14.25%-7.56M-75.04%-20.7M
-Change in receivables -264.16%-115.8M-484.71%-51.48M-1,799.80%-50.69M-77.75%-19.31M137.49%5.67M-674.11%-31.8M-220.60%-8.8M-7.07%2.98M-604.80%-10.86M-340.86%-15.12M
-Change in inventory -188.77%-17.92M-550.77%-2.96M125.08%938K-369.07%-7.16M-86.98%-8.73M24.15%-6.2M35.55%-455K-9.10%-3.74M241.39%2.66M-115.90%-4.67M
-Change in prepaid assets 92.82%-183K107.25%3.12M366.70%9.64M-301.57%-7.82M-18.73%-5.12M74.80%-2.55M126.72%1.5M-123.62%-3.62M104.16%3.88M9.61%-4.32M
-Change in payables and accrued expense 45.07%9.85M60.89%11.15M277.89%10.95M-523.08%-1.76M-287.34%-10.49M124.16%6.79M565.86%6.93M-188.41%-6.16M113.49%416K776.21%5.6M
-Change in other current liabilities 114.88%158K-14.54%-1.31M5,407.69%1.43M---------1,267.03%-1.06M-5,065.22%-1.14M2,500.00%26K-42.22%26K27.27%28K
-Change in other working capital 39.63%-8.49M54.52%-2.19M35.58%-2.16M43.11%-2.11M7.37%-2.04M-66.68%-14.07M-123.13%-4.81M-58.98%-3.35M-80.40%-3.71M-3.63%-2.2M
Cash from discontinued investing activities
Operating cash flow -172.56%-10.31M260.43%39.42M-64.59%3.08M-793.82%-32.87M-96.17%-19.94M-54.04%14.21M3.04%10.94M-48.04%8.7M-45.20%4.74M-100.16%-10.16M
Investing cash flow
Cash flow from continuing investing activities -41.06%-14.15M-38.41%-4.65M13.00%-2.24M-93.51%-3.64M-63.19%-3.63M58.82%-10.03M-1.11%-3.36M57.03%-2.57M74.93%-1.88M70.62%-2.22M
Net PPE purchase and sale -41.06%-14.15M-38.41%-4.65M13.00%-2.24M-93.51%-3.64M-63.19%-3.63M58.82%-10.03M-1.11%-3.36M57.03%-2.57M74.93%-1.88M70.62%-2.22M
Cash from discontinued investing activities
Investing cash flow -41.06%-14.15M-38.41%-4.65M13.00%-2.24M-93.51%-3.64M-63.19%-3.63M58.82%-10.03M-1.11%-3.36M57.03%-2.57M74.93%-1.88M70.62%-2.22M
Financing cash flow
Cash flow from continuing financing activities -162.81%-17.36M-114.29%-4.81M-508.65%-10.21M83.32%-288K21.17%-2.06M602.03%27.64M1,993.58%33.65M-16.62%-1.68M-63.85%-1.73M-111.00%-2.61M
Net issuance payments of debt 98.27%-1.17M99.52%-302K82.40%-296K82.79%-288K82.91%-285K-1,207.64%-67.64M-3,421.99%-62.62M-17.05%-1.68M-64.02%-1.67M-77.83%-1.67M
Net common stock issuance --0-------------------25.48M----------------
Net preferred stock issuance --0------------------120.69M----------------
Proceeds from stock option exercised by employees -87.41%157K-99.81%2K3,150.00%130K--0-86.11%25K--1.25M--1.06M--4K--0--180K
Net other financing activities -1,291.15%-16.35M-225,350.00%-4.51M-1,004,200.00%-10.04M--0-60.36%-1.8M-253.92%-1.18M-300.00%-2K200.00%1K-58.82%-54K-275.84%-1.12M
Cash from discontinued financing activities
Financing cash flow -162.81%-17.36M-114.29%-4.81M-508.65%-10.21M83.32%-288K21.17%-2.06M602.03%27.64M1,993.58%33.65M-16.62%-1.68M-63.85%-1.73M-111.00%-2.61M
Net cash flow
Beginning cash position 30.49%136.15M-32.19%64.37M-18.50%73.74M23.71%110.53M30.49%136.15M1.01%104.34M-3.95%94.93M1.08%90.48M-0.08%89.35M1.01%104.34M
Current changes in cash -231.46%-41.82M-27.33%29.96M-310.45%-9.36M-3,353.67%-36.8M-70.87%-25.62M2,935.59%31.81M647.78%41.23M-52.25%4.45M1,116.13%1.13M-8.05%-14.99M
End cash Position -30.72%94.33M-30.72%94.33M-32.19%64.37M-18.50%73.74M23.71%110.53M30.49%136.15M30.49%136.15M-3.95%94.93M1.08%90.48M-0.08%89.35M
Free cash flow -685.73%-24.46M358.92%34.77M-86.22%844K-1,377.50%-36.51M-90.25%-23.56M-36.27%4.18M3.92%7.58M-43.04%6.13M149.17%2.86M2.02%-12.38M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, in accordance with the Lebanon ceasefire agreement, announced Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -